Sign up to save your podcasts
Or
Share 2025 Diagnostic Trends and Innovations
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
2025 Diagnostic Trends and Innovations
Our 54th episode of QuidelOrtho Science Bytes features Jonathan Siegrist, PhD, Executive Vice President of Research & Development and Chief Technology Officer, exploring the breakthroughs shaping diagnostics in 2025.
From high-sensitivity troponin testing for faster cardiac care to non-invasive assays improving gastrointestinal health, rapid combo tests for respiratory surges and advances in molecular diagnostics, informatics and AI – these innovations are transforming workflows, guiding timely decisions and redefining patient care across the continuum.
Dr. Siegrist shares how cutting-edge research and next-generation platforms are driving smarter diagnostics – delivering fast, reliable insights that empower clinicians and improve outcomes worldwide.
About Our Speaker:
Jonathan Siegrist, PhD
Executive Vice President of Research & Development & Chief Technology Officer at QuidelOrtho
Jonathan is responsible for the company’s global R&D strategy, driving innovation and advancing next-generation diagnostic solutions. He brings over 15 years of leadership experience in the biotechnology and diagnostics industries, with a focus on molecular diagnostics, microfluidic platforms and biomedical engineering. Before joining QuidelOrtho, Jonathan served as Chief Technology Officer and head of assay research and development at Cepheid. Throughout his career, he has been recognized for his ability to lead complex, multidisciplinary teams while fostering a culture of creativity and innovation. Jonathan holds a PhD and Master of Science in biomedical engineering from the University of California, Irvine, and a Bachelor of Science in electrical engineering from the University of California, Los Angeles.
View all episodes
By QuidelOrtho
4.9
1616 ratings
Our 54th episode of QuidelOrtho Science Bytes features Jonathan Siegrist, PhD, Executive Vice President of Research & Development and Chief Technology Officer, exploring the breakthroughs shaping diagnostics in 2025.
From high-sensitivity troponin testing for faster cardiac care to non-invasive assays improving gastrointestinal health, rapid combo tests for respiratory surges and advances in molecular diagnostics, informatics and AI – these innovations are transforming workflows, guiding timely decisions and redefining patient care across the continuum.
Dr. Siegrist shares how cutting-edge research and next-generation platforms are driving smarter diagnostics – delivering fast, reliable insights that empower clinicians and improve outcomes worldwide.
About Our Speaker:
Jonathan Siegrist, PhD
Executive Vice President of Research & Development & Chief Technology Officer at QuidelOrtho
Jonathan is responsible for the company’s global R&D strategy, driving innovation and advancing next-generation diagnostic solutions. He brings over 15 years of leadership experience in the biotechnology and diagnostics industries, with a focus on molecular diagnostics, microfluidic platforms and biomedical engineering. Before joining QuidelOrtho, Jonathan served as Chief Technology Officer and head of assay research and development at Cepheid. Throughout his career, he has been recognized for his ability to lead complex, multidisciplinary teams while fostering a culture of creativity and innovation. Jonathan holds a PhD and Master of Science in biomedical engineering from the University of California, Irvine, and a Bachelor of Science in electrical engineering from the University of California, Los Angeles.
More shows like QuidelOrtho Science BYTES Podcast
View all
Stuff You Should Know
78,614 Listeners
RedHanded
12,580 Listeners
New Heights with Jason & Travis Kelce
18,188 Listeners